|
Imetelstat Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: GRN 163L, GRN-163L, GRN163L
Birmingham, Alabama1 trial
New York, New York1 trial
Imetelstat Combinations in Relapsed AML
Icahn School of Medicine at Mount Sinai
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.